2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$5.57+$0.22 (+4.04%)
Price as of Aug 03, 2026 10:20 AM EDT- $192.7MMarket Cap
- 404.72%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$5.57+$0.22 (+4.04%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.35 | ||
Change | +$0.02 (+0.38%) | ||
Open | $5.37 | ||
High | $5.66 | ||
Low | $5.26 | ||
Previous Close | $5.33 | ||
Volume | 250,627 | ||
30-Day Average Volume | 207,349 | ||
1-Week Change | 8.74% | ||
1-Month Change | 10.54% | ||
1-Year Change | 404.72% | ||
3-Year Change | -34.11% | ||
5-Year Change | -90.59% | ||
Fundamentals | |||
Shares Outstanding | 36.0M | ||
Total Assets | $87.5M | ||
Market Cap | $192.7M | ||
Enterprise Value | $139.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$12.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -18 | ||
PEG | 17 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue